- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 05:06 | Bullion Gold Resources Corp (2): Bullion hires ITG as market-maker, arranges financing | 1 | Stockwatch | ||
| Di | Bullion Gold Resources Corporation: Bullion Gold Engages Independent Trading Group as Market Maker, Announces Private Placement. | 581 | Newsfile | Montreal, Quebec--(Newsfile Corp. - October 21, 2025) - Bullion Gold Resources (TSXV: BGD) ("Bullion Gold" or "The Company") announces that, subject to regulatory approval, it has engaged the services... ► Artikel lesen | |
| BULLION GOLD RESOURCES Aktie jetzt für 0€ handeln | |||||
| 10.10. | Bullion Gold Resources Corp (2): Bullion Gold identifies Au grains at Cadillac-Extension | 1 | Stockwatch | ||
| 09.10. | Bullion Gold Resources Corporation: Bullion Gold Identifies Coarse, Irregular Gold Grains North of Langlade VMS Prospect (Cadillac-Extension Project), Launches Expanded Basal Till Sampling Program. | 228 | Newsfile | Montreal, Quebec--(Newsfile Corp. - October 9, 2025) - Bullion Gold Resources (TSXV: BGD) ("Bullion Gold" or "The Company") is pleased to announce encouraging preliminary results from a test basal... ► Artikel lesen | |
| 04.10. | Bullion Gold Resources Corp (2): Bullion Gold Resources private placement | 1 | Stockwatch | ||
| 02.10. | Bullion Gold Resources Corp (2): Bullion Gold's Canico samples return up to 2.16 g/t Au | 1 | Stockwatch | ||
| 02.10. | Bullion Gold Resources Corporation: Bullion Gold Confirms a Promising New Polymetallic Showing at Bodo and Identifies a Potential IOCG/SKARN-type Target | 318 | Newsfile | Montreal, Quebec--(Newsfile Corp. - October 2, 2025) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or the "Company") is pleased to announce the confirmation of the polymetallic character... ► Artikel lesen | |
| 30.09. | Bullion Gold Resources Corporation: Bousquet Drilling Demonstrates Down Dip Potential at Paquin | 286 | Newsfile | Montreal, Quebec--(Newsfile Corp. - September 30, 2025) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or the "Company") is pleased to announce that its partner Olympio Metals has just... ► Artikel lesen | |
| 17.09. | Bullion Gold Resources Corp (2): Bullion Gold sets out Quebec project exploration work | 1 | Stockwatch | ||
| 16.09. | Bullion Gold Resources Corporation: Bullion Gold Provides Updates on Its Bousquet, Langlade, and Bodo (Rivon Zone) Exploration Projects | 314 | Newsfile | Montreal, Quebec--(Newsfile Corp. - September 16, 2025) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or the "Company") is pleased to provide an update on the progress of its exploration... ► Artikel lesen | |
| 29.08. | Bullion Gold Resources Corp (2): Bullion Gold samples up to 15.5% Cu, 137 g/t Ag at Bodo | 1 | Stockwatch | ||
| 28.08. | Bullion Gold Resources Corporation: Bullion Samples Up to 15.5% Cu, 137 G/t Ag and 6.85 G/t Au at the Bodo Project and Identifies a New Gold Target at Holton Creek | 363 | Newsfile | Montreal, Quebec--(Newsfile Corp. - August 28, 2025) - Bullion Gold Resource Corp. (TSXV: BGD) ("Bullion Gold" or the "Company") is pleased to announce the first assay results from surface sampling... ► Artikel lesen | |
| 27.08. | Bullion Gold Resources Corp (2): Bullion, Olympio drill 14.5m of 1.96 g/t Au at Bousquet | 1 | Stockwatch | ||
| 26.08. | Bullion Gold Resources Corporation: Continued Success of Bousquet Gold Drilling with First Holes at Decoeur Prospect | 384 | Newsfile | Montreal, Quebec--(Newsfile Corp. - August 26, 2025) - Bullion Gold Resources (TSXV: BGD) ("Bullion Gold" or "The Company") and its partner Olympio Metals Limited ("Olympio") are pleased to announce... ► Artikel lesen | |
| 18.08. | ABC Bullion: Gold falls, silver 'muted' as Bitcoin rallies: Gold prices fell marginally week-on-week, easing ... | 4 | Mining.com.au | ||
| 14.08. | Bullion Gold Resources Corp (2): Bullion Gold completes field prospecting at Bodo | 2 | Stockwatch | ||
| 14.08. | Bullion Gold Resources Corporation: Bullion Gold Expands the Lac Rivon West Copper System, Tichegami - Eeyou Istchee Baie-James | 430 | Newsfile | Montreal, Quebec--(Newsfile Corp. - August 14, 2025) - Bullion Gold Resources (TSXV: BGD) ("Bullion Gold" or the "Company") announces the completion of a field prospecting program on its wholly owned... ► Artikel lesen | |
| 13.08. | Bullion Gold Resources Corp (2): Bullion drilling shows shallow gold over 200 m strike | 1 | Stockwatch | ||
| 13.08. | Bullion Gold Resources Corporation: Drilling at Amadee Prospect Confirms Shallow Gold Mineralisation | 498 | Newsfile | Montreal, Quebec--(Newsfile Corp. - August 12, 2025) - Bullion Gold Resources (TSXV: BGD) ("Bullion Gold" or the "Company") and its partner Olympio Metals Limited are pleased to announce that results... ► Artikel lesen | |
| 05.08. | Bullion Gold Resources Corporation: Further High-Grade Gold Intersections at Bousquet | 475 | Newsfile | Montreal, Quebec--(Newsfile Corp. - August 5, 2025) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or the "Company") and its partner Olympio Metals Limited are pleased to announce that... ► Artikel lesen |
1 2 3 Weiter >>
44 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| QIAGEN | 42,065 | -0,10 % | QIAGEN N.V. to Release Results for Q3 2025 and Hold Webcast | QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) today announced plans to release results for the third quarter of 2025.
Press release date time: Tuesday, November 4, shortly after 22:05... ► Artikel lesen | |
| EVOTEC | 6,726 | -1,41 % | Aixtron, Evotec, Hensoldt, Puma, Ströer, Suss MicroTec - Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| RANI THERAPEUTICS | 2,830 | -1,74 % | Rani Therapeutics Announces up to $1.085 Billion Collaboration with Chugai Pharmaceutical Co. for Multiple High-Value Therapeutics Including Rare Disease and Immunology Programs and Announces Concurrent Oversubscribed $60.3 ... | Rani will receive $10 million upfront payment and is eligible to receive up to $75 million in technology transfer and development milestones, up to $100 million in sales milestones and single digit... ► Artikel lesen | |
| JYONG BIOTECH | 60,00 | 0,00 % | Jyong Biotech Ltd.: Jyong Biotech Announces Completion of Patient Enrollment of over 700 subjects in Phase II Clinical Trial of MCS-8 for Prostate Cancer Prevention | New Taipei City, Taiwan, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the "Company", "Jyong Biotech"), a science-driven biotechnology company based in Taiwan committed to... ► Artikel lesen | |
| ARCTURUS THERAPEUTICS | 9,210 | -60,22 % | Arcturus Therapeutics Provides Interim Phase 2 Data for Cystic Fibrosis Program | ARCT-032 generally safe and well tolerated
Meaningful trends of clinical activity observed via high resolution CT scans
After only 28 days of treatment with ARCT-032 (10 mg), 4 out of 6 Class... ► Artikel lesen | |
| BIONTECH | 91,30 | -1,03 % | Übernahmefieber und KI-Chance: BioNTech, Novo Nordisk, PanGenomic Health Aktie | Übernahmefieber im Pharma- und Biotech-Bereich. Novo Nordisk hat nach der angekündigten Milliardenübernahme in den USA den nächsten Deal gemeldet. Die Dänen sehen ein mögliches Best-in-Class-Therapeutikum... ► Artikel lesen | |
| NURIX THERAPEUTICS | 10,570 | +1,34 % | Nurix Therapeutics, Inc.: Nurix Initiates DAYBreak Pivotal Study of Bexobrutideg in Relapsed or Refractory Chronic Lymphocytic Leukemia | 600 mg once daily bexobrutideg oral dose cleared by global regulators for pivotal monotherapy trials in relapsed/refractory chronic lymphocytic leukemia (r/r CLL) Phase 2 DAYBreak trial initiated... ► Artikel lesen | |
| RECURSION PHARMACEUTICALS | 5,690 | -6,87 % | Recursion Pharmaceuticals (RXRX) Surges 14% Ahead of Earnings | ||
| SUMMIT THERAPEUTICS | 19,040 | +1,38 % | Summit Therapeutics: Daten überzeugen - BioNTech beobachten! | Am morgigen Dienstag neigt sich die Jahrestagung der European Society for Medical Oncology (ESMO) in Berlin schon wieder dem Ende entgegen. Zahlreiche Unternehmen haben bereits am Wochenende frische... ► Artikel lesen | |
| COGENT BIOSCIENCES | 14,510 | -8,51 % | Cogent Biosciences, Inc.: Cogent Biosciences Announces FDA Breakthrough Therapy Designation for Bezuclastinib | Detailed results from bezuclastinib's positive SUMMIT trial evaluating bezuclastinib in patients with NonAdvanced Systemic Mastocytosis planned for presentation at upcoming scientific conference this... ► Artikel lesen | |
| SANA BIOTECHNOLOGY | 5,230 | -8,25 % | Sana Biotech surges as Eric Jackson calls it a 100-bagger | ||
| DISC MEDICINE | 88,50 | +2,73 % | Disc Medicine Inc: Disc Medicine Provides Update on Hematology Portfolio and Outlines Near-Term Business Objectives and Anticipated Milestones | Submitted a New Drug Application (NDA) for accelerated approval of bitopertin in erythropoietic protoporphyria (EPP) on September 29, 2025, and subsequently was awarded the FDA Commissioner's National... ► Artikel lesen | |
| JANUX THERAPEUTICS | 25,500 | -5,03 % | Janux Therapeutics: Günstige Gelegenheit | Janux Therapeutics hat mit seiner innovativen Plattformtechnologie im letzten Jahr das Interesse vieler Investoren geweckt - nicht zuletzt aufgrund von Übernahmegerüchten. Doch unabhängig von einem... ► Artikel lesen | |
| BIOGEN | 127,50 | +1,15 % | Biogen Inc.: Biogen to Present Additional Results from Phase 3 Study of Dapirolizumab Pegol in Systemic Lupus Erythematosus at ACR Convergence 2025 | Dapirolizumab pegol (DZP) Phase 3 study presentations in SLE to show efficacy results across multiple clinical endpoints, including low disease activity/remission, flares, fatigue, joint pain and quality... ► Artikel lesen | |
| SIONNA THERAPEUTICS | 38,890 | -8,77 % | Sionna Therapeutics, Inc.: Sionna Therapeutics Announces Initiation of PreciSION CF Phase 2a Trial Evaluating NBD1 Stabilizer, SION-719, When Added to Standard of Care in Participants with Cystic Fibrosis | SION-719 is the first NBD1 stabilizer being evaluated in people living with cystic fibrosis Topline data expected in mid-2026 WALTHAM, Mass., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Sionna Therapeutics... ► Artikel lesen |
BULLION GOLD RESOURCES CORPORATION gehört der Branche Biotechnologie an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BULLION GOLD RESOURCES CORPORATION finden Sie auf Wallstreet Online.